This HTML5 document contains 135 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44793011
rdf:type
wikibase:Item
schema:description
vedecký článok articol științific artigo científico 2004年學術文章 2004年学术文章 2004年学术文章 vitskapeleg artikkel wissenschaftlicher Artikel 2004年学术文章 научни чланак 2004年學術文章 2004 nî lūn-bûn научни чланак מאמר מדעי মার্চ ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikull shkencor artykuł naukowy научна статия naučni članak scientific article published in March 2004 bài báo khoa học 2004년 논문 επιστημονικό άρθρο artigo científico 2004年学术文章 2004年學術文章 artículu científicu artículo científico publicado en 2004 บทความทางวิทยาศาสตร์ scienca artikolo teaduslik artikkel vědecký článek artikel ilmiah article científic article scientific scientific article published in March 2004 2004年學術文章 bilimsel makale مقالة علمية نشرت في مارس 2004 articolo scientifico artigo científico наукова стаття, опублікована в березні 2004 სამეცნიერო სტატია 2004年学术文章 2004年学术文章 мақолаи илмӣ 2004年學術文章 tudományos cikk scientific article published in March 2004 vitenskapelig artikkel vetenskaplig artikel 2004年の論文 artikulong pang-agham tieteellinen artikkeli videnskabelig artikel wetenschappelijk artikel научная статья article scientifique
p:P577
wds:Q44793011-794B3758-45A2-447B-B165-433CD9732A60
wdt:P577
2004-03-01T00:00:00Z
p:P2860
wds:Q44793011-0DA5E0BD-0C92-44D5-A2C9-78C575F2B85D wds:Q44793011-DB5DE3F9-720E-4674-9658-3BB0636BF8F3 wds:Q44793011-9730E439-B91B-47A2-833F-6F00209273F4 wds:Q44793011-F51EA16C-8928-42F9-8303-D9B29EB4F7FD wds:Q44793011-FBFFEA0B-A2D2-4877-BF11-9347FD74796B wds:Q44793011-FE6A30C7-E4D7-4359-8570-18814EBF2BDE wds:Q44793011-6C352886-81E8-466E-8DD1-2F2B36DEF6EA wds:Q44793011-6D3E0C10-65CC-4FEA-A8B7-B2BD508989D2 wds:Q44793011-649D80F3-84DA-468B-81DE-8828AC384B93 wds:Q44793011-8564675D-EF74-4980-B841-C022FD59812E wds:Q44793011-94E27F0A-AE54-471F-B653-06E59300BF56
wdt:P2860
wd:Q37946849 wd:Q28036762 wd:Q53810566 wd:Q53623862 wd:Q34223561 wd:Q24550555 wd:Q44120190 wd:Q34734009 wd:Q43651884 wd:Q43584187 wd:Q33891624
p:P2093
wds:Q44793011-4B46C6BD-CBAD-4D8F-8FA8-BA5174C500C7 wds:Q44793011-5EC2B50B-06CE-4D94-8E45-AE6D76B1C3D8 wds:Q44793011-AE9BED32-CA27-423D-B892-4AEAB0A3E6E1 wds:Q44793011-B188A151-AE59-432E-BF55-822C479B3791 wds:Q44793011-A6A54C58-C952-4BAC-87F0-C0AA03FB39D7 wds:Q44793011-2F01350E-1A59-4521-8A94-4FC2FCE5A90E wds:Q44793011-1462BEDA-9AA0-4AD7-B83C-7DEBD9AD0E89 wds:Q44793011-1FB87898-A0CF-4506-8C00-94F6C86D042E
wdt:P2093
Rex W Force Gabriel Habib Henry Black Allan Ellsworth Jerry O Ciocon ALLHAT Collaborative Research Group Judy Bettencourt Jan N Basile
rdfs:label
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study
skos:prefLabel
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study
schema:name
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study
p:P50
wds:Q44793011-d112e820-4453-ee17-4e78-b7b3f7fa0a76 wds:Q44793011-7a42771f-4714-7f4a-218a-56b0d0b7878a wds:Q44793011-804DC5F1-6C8B-46B5-BAFD-3F0E083B7F2D wds:Q44793011-884574BD-4E30-4713-936D-40296A845C2C wds:Q44793011-6aa831a1-4c33-580f-7d8c-2a5a9160d2cc
wdt:P50
wd:Q64684716 wd:Q96109271 wd:Q116024949 wd:Q91071768 wd:Q67453328
p:P1476
wds:Q44793011-33D9687E-6973-4DA4-A477-75F0309DC9C6
wdt:P1476
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study
p:P304
wds:Q44793011-63A00C37-04BE-4790-A98E-3DC4CD42D8AE
wdt:P304
116-125
p:P31
wds:Q44793011-E3C379AF-C15A-4F15-81EC-43AE9DA18D78
wdt:P31
wd:Q13442814
p:P698
wds:Q44793011-8163D206-64AF-4B40-8D8B-1D1709FEA6C0
wdtn:P698
n12:15010644
wdt:P698
15010644
p:P1433
wds:Q44793011-67025F7B-CA9A-4C87-A159-CD0A2189A54F
wdt:P1433
wd:Q15764150
p:P433
wds:Q44793011-13B7F298-1A44-4B69-BEF5-6554BACCEB11
p:P478
wds:Q44793011-DFC3A9A7-F200-487A-892F-97EB8F83D0D0
wdt:P433
3
wdt:P478
6
p:P356
wds:Q44793011-7F5A8AB3-2078-414A-BFC9-A1C0883A4157
wdtn:P356
n9:J.1524-6175.2004.03216.X
wdt:P356
10.1111/J.1524-6175.2004.03216.X
p:P5875
wds:Q44793011-D5A52DB0-5B8E-4C9A-865B-EC8C27E6E998
wdt:P5875
5487099